clinical 4,197 words KG: OVERVIEW 2026-03-28
kind:clinical-trialsection:clinical-trialsstate:publishedcategory:biomarkerscategory:neuroimagingevidence:strong
Contents

FEEMSA Study: Laryngopharyngeal Function in Neurodegenerative Diseases (NCT04706234)

Knowledge Graph

Related Hypotheses (10)

SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.49
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Lysosomal Enzyme Trafficking Correction
Score: 0.49
Lysosomal Membrane Repair Enhancement
Score: 0.45

Related Analyses (14)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived

Related Experiments (3)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Iron Dyshomeostasis in MSA Pathogenesis Experiment
validation · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40

Knowledge Graph (12 edges)

OVERVIEW biomarker_for BRAF
OVERVIEW biomarker_for ATRX
OVERVIEW activates VALOSIN
OVERVIEW therapeutic_target CXCR1
OVERVIEW regulates LETM1
OVERVIEW regulates MCU
OVERVIEW activates CHMP2B
OVERVIEW activates TARDBP
OVERVIEW activates LC3
OVERVIEW activates TBK1